global+growth

Indian's NPPA has allowed a one-time price increase of 50% on the price of Heparin injection — used in treatment of Covid-19 patients.

The Africa Union calls for an “equitable and timely distribution” of a Covid-19 vaccine by partnering with the COVID-19 Vaccine Global Access, or Covax.

Researchers are looking at how to ensure equitable distribution of a COVID-19 vaccine for countries most vulnerable to the coronavirus outbreak.

The privately held company said it would supply 20,000 vials of the drug.

Stocks of medication for HIV patients could run out in the next two months, because of higher costs linked to lockdowns and COVID-19 border closures.

The oral antiviral drug, favipiravir, which is being used to treat patients with mild to moderate symptoms and infection will now also be available in the Indian market by the name FabiFlu.

The World Health Organization announced during a media briefing on Wednesday that it would add the drug dexamathasone to its clinical guidelines on COVID-19, the disease caused by the novel coronavirus.

Thai epidemiologists say their health care system — one of the finest in the world — had a major role to play. So did a strict lockdown.

If the U.S. wants lower costs, better outcomes, faster innovation and universal access, it should look to the country that has the closest thing to a functioning health-care market: Singapore.

Senior SCMP journalist Josephine Ma reports the latest on vaccine testing in mainland China, the deep ethical concerns over 'human challenge' trials and the reality of political promises of a vaccine to be ready by September.

If an effective COVID-19 vaccine is developed, how will it get to everyone in need? Ann Danaiya Usher reports on the initiatives being planned to ensure equitable access, and their shortcomings.

Any vaccine for the coronavirus should be made available as a global public good, the World Health Organization said.

With human trials for their vaccine beginning next week, Imperial College London is creating the new business to make sure it will be accessible to all if successful.

Some African countries have been criticized for not issuing accurate data on COVID-19.

NorLevo is among the drugs that are not covered by insurance companies in Rwanda, therefore the prices are manipulated by private pharmacists.